MedTrace Logo

REPEAT - Real-Life Perception of Efficacy, Attitude, Satisfaction and Safety of Levitra Therapy

NCT00874679 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 7293

Last updated 2011-11-11

No results posted yet for this study

Summary

The aim of this prospective, non-interventional post-marketing surveillance study is to obtain data on safety and efficacy of Levitra in routine treatment of erectile dysfunction. Furthermore, the data collection particularly focuses on the experience of the patient and his satisfaction with the treatment. Treatment naive patients as well as pre-treated patients will be included in the study.The maximum observation period per patient is 12 months.Besides the physician's documentation, the patient should fill out a questionnaire at every visit. The questionnaires will be handed out and collected by the physician. Furthermore, an additional questionnaire for the patient's partner can be distributed at each visit in case the partner is willing to participate.

Conditions

Interventions

DRUG

Levitra (Vardenafil, BAY38-9456)

Patients with diagnosis of erectile dysfunction who get vardenafil in routine treatment

Sponsors & Collaborators

Principal Investigators

  • Bayer Study Director · Bayer

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-03-31
Primary Completion
2010-04-30
Completion
2010-04-30

Countries

  • China
  • Croatia
  • France
  • Germany
  • Hungary
  • Indonesia
  • Malaysia
  • Poland
  • Saudi Arabia
  • Singapore
  • South Africa
  • South Korea
  • Spain
  • Sweden
  • Thailand

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00874679 on ClinicalTrials.gov